PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY APPLICATION • Segmentation by application • Comparison by application • Microbial and infectious disease testing – Market size and forecast 2017-2022 • Hematology testing – Market size and forecast 2017-2022 • Cardiac and lipid testing – Market size and forecast 2017-2022 • Coagulation testing – Market size and forecast 2017-2022 • Blood glucose testing – Market size and forecast 2017-2022 • Fecal occult testing – Market size and forecast 2017-2022 • Others – Market size and forecast 2017-2022 • Market opportunity by application PART 08: CUSTOMER LANDSCAPE PART 09: MARKET SEGMENTATION BY END-USER • Segmentation by end-user PART 10: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas – Market size and forecast 2017-2022 • EMEA – Market size and forecast 2017-2022 • APAC – Market size and forecast 2017-2022 • Market opportunity PART 11: DECISION FRAMEWORK PART 12: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 13: MARKET TRENDS • Data management and connectivity to EHRs through interoperability • Focus on next-generation technologies • Increasing online marketing of critical care diagnostics PART 14: VENDOR LANDSCAPE • Overview • Landscape disruption • Competitive landscape PART 15: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Abbott • BD • bioMérieux • Danaher • F. Hoffmann-La Roche • Siemens Healthcare • Other prominent vendors PART 16: APPENDIX • List of abbreviations Exhibit 01: Parent market Exhibit 02: Global IVD market segmentation Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global – Market size and forecast 2017-2022 ($ mn) Exhibit 09: Global – Year-over-year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2017 Exhibit 18: Application – Market share 2017-2022 (%) Exhibit 19: Comparison by application Exhibit 20: Microbial and infectious disease testing – Market size and forecast 2017-2022 ($ mn) Exhibit 21: Microbial and infectious disease testing – Year-over-year growth 2018-2022 (%) Exhibit 22: Hematology testing – Market size and forecast 2017-2022 ($ mn) Exhibit 23: Hematology testing – Year-over-year growth 2018-2022 (%) Exhibit 24: Cardiac and lipid testing – Market size and forecast 2017-2022 ($ mn) Exhibit 25: Cardiac and lipid testing – Year-over-year growth 2018-2022 (%) Exhibit 26: Coagulation testing – Market size and forecast 2017-2022 ($ mn) Exhibit 27: Coagulation testing – Year-over-year growth 2018-2022 (%) Exhibit 28: Blood glucose testing – Market size and forecast 2017-2022 ($ mn) Exhibit 29: Blood glucose testing – Year-over-year growth 2018-2022 (%) Exhibit 30: Fecal occult testing – Market size and forecast 2017-2022 ($ mn) Exhibit 31: Fecal occult testing – Year-over-year growth 2018-2022 (%) Exhibit 32: Others – Market size and forecast 2017-2022 ($ mn) Exhibit 33: Others – Year-over-year growth 2018-2022 (%) Exhibit 34: Market opportunity by application Exhibit 35: Customer landscape Exhibit 36: Global critical care diagnostics market by end-users - Market share (%) Exhibit 37: Global – Market share by geography 2017-2022 (%) Exhibit 38: Regional comparison Exhibit 39: Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 40: Americas – Year-over-year growth 2018-2022 (%) Exhibit 41: Top three countries in Americas Exhibit 42: EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 43: EMEA – Year-over-year growth 2018-2022 (%) Exhibit 44: Top three countries in EMEA Exhibit 45: APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 46: APAC – Year-over-year growth 2018-2022 (%) Exhibit 47: Top three countries in APAC Exhibit 48: Market opportunity Exhibit 49: M&A activities Exhibit 50: Vendor landscape Exhibit 51: Landscape disruption Exhibit 52: Vendors covered Exhibit 53: Vendor classification Exhibit 54: Market positioning of vendors Exhibit 55: Abbott – Overview Exhibit 56: Abbott – Business segments Exhibit 57: Abbott – Organizational developments Exhibit 58: Abbott – Geographic focus Exhibit 59: Abbott – Segment focus Exhibit 60: Abbott – Key offerings Exhibit 61: Abbott – Key customers Exhibit 62: BD – Overview Exhibit 63: BD – Business segments Exhibit 64: BD – Organizational developments Exhibit 65: BD – Geographic focus Exhibit 66: BD – Segment focus Exhibit 67: BD – Key offerings Exhibit 68: BD – Key customers Exhibit 69: bioMérieux – Overview Exhibit 70: bioMérieux – Business segments Exhibit 71: bioMérieux – Organizational developments Exhibit 72: bioMérieux – Geographic focus Exhibit 73: bioMérieux – Segment focus Exhibit 74: bioMérieux – Key offerings Exhibit 75: bioMérieux – Key customers Exhibit 76: Danaher – Overview Exhibit 77: Danaher – Business segments Exhibit 78: Danaher – Organizational developments Exhibit 79: Danaher – Geographic focus Exhibit 80: Danaher – Segment focus Exhibit 81: Danaher – Key offerings Exhibit 82: Danaher – Key customers Exhibit 83: F. Hoffmann-La Roche – Overview Exhibit 84: F. Hoffmann-La Roche – Business segments Exhibit 85: F. Hoffmann-La Roche – Organizational developments Exhibit 86: F. Hoffmann-La Roche – Geographic focus Exhibit 87: F. Hoffmann-La Roche – Segment focus Exhibit 88: F. Hoffmann-La Roche – Key offerings Exhibit 89: F. Hoffmann-La Roche – Key customers Exhibit 90: Siemens Healthcare – Overview Exhibit 91: Siemens Healthcare – Business segments Exhibit 92: Siemens Healthcare – Organizational developments Exhibit 93: Siemens Healthcare – Geographic focus Exhibit 94: Siemens Healthcare – Segment focus Exhibit 95: Siemens Healthcare – Key offerings Exhibit 96: Siemens Healthcare – Key customers

Abbott BD bioMérieux Danaher F. Hoffmann-La Roche Siemens Healthcare